Loading…

Dyslipidemia in retinal metabolic disorders

The light‐sensitive photoreceptors in the retina are extremely metabolically demanding and have the highest density of mitochondria of any cell in the body. Both physiological and pathological retinal vascular growth and regression are controlled by photoreceptor energy demands. It is critical to un...

Full description

Saved in:
Bibliographic Details
Published in:EMBO molecular medicine 2019-10, Vol.11 (10), p.e10473-n/a
Main Authors: Fu, Zhongjie, Chen, Chuck T, Cagnone, Gael, Heckel, Emilie, Sun, Ye, Cakir, Bertan, Tomita, Yohei, Huang, Shuo, Li, Qian, Britton, William, Cho, Steve S, Kern, Timothy S, Hellström, Ann, Joyal, Jean‐Sébastien, Smith, Lois EH
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The light‐sensitive photoreceptors in the retina are extremely metabolically demanding and have the highest density of mitochondria of any cell in the body. Both physiological and pathological retinal vascular growth and regression are controlled by photoreceptor energy demands. It is critical to understand the energy demands of photoreceptors and fuel sources supplying them to understand neurovascular diseases. Retinas are very rich in lipids, which are continuously recycled as lipid‐rich photoreceptor outer segments are shed and reformed and dietary intake of lipids modulates retinal lipid composition. Lipids (as well as glucose) are fuel substrates for photoreceptor mitochondria. Dyslipidemia contributes to the development and progression of retinal dysfunction in many eye diseases. Here, we review photoreceptor energy demands with a focus on lipid metabolism in retinal neurovascular disorders. Graphical Abstract In the growing field of lipid metabolism in retinopathies, this review provides insights on the possible implication of lipid metabolism, energy demands and fuel source in the retina, but also systemic dyslipidemia on neovascular retinopathy.
ISSN:1757-4676
1757-4684
DOI:10.15252/emmm.201910473